Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Change in prostate volume measured in cm^3
Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.
One month post implant
No
William St. Clair, MD
Principal Investigator
Lucille P. Markey Cancer Center at University of Kentucky
United States: Food and Drug Administration
13-RAD-01
NCT01810627
March 2013
April 2015
Name | Location |
---|---|
Markey Cancer Center | Lexington, Kentucky 40536 |